<i>Caenorhabditis elegans</i>: A versatile platform for drug discovery

DOI Web Site Web Site 被引用文献1件

説明

<jats:title>Abstract</jats:title><jats:p>Drug discovery and drug target identification are two intimately linked facets of intervention strategies aimed at effectively combating pathological conditions in humans. Simple model organisms provide attractive platforms for devising and streamlining efficient drug discovery and drug target identification methodologies. The nematode worm <jats:italic>Caenorhabditis elegans</jats:italic> has emerged as a particularly convenient and versatile tool that can be exploited to achieve these goals. Although <jats:italic>C. elegans</jats:italic> is a relatively modern addition to the arsenal of model organisms, its biology has already been investigated to an exceptional level. This, coupled with effortless handling and a notable low cost of cultivation and maintenance, allows seamless implementation of high‐throughput drug screening approaches as well as in‐depth genetic and biochemical studies of the molecular pathways targeted by specific drugs. In this review, we introduce <jats:italic>C. elegans</jats:italic> as a model organism with significant advantages toward the identification of molecular drug targets. In addition, we discuss the value of the worm in the development of drug screening and drug evaluation protocols. The unique features of <jats:italic>C. elegans</jats:italic>, which greatly facilitate drug studies, hold promise for both deciphering disease pathogenesis and formulating educated and effective therapeutic interventions.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ